The International Trade Administration published notices in the April 5 Federal Register on the following AD/CV duty proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms, or effective dates will be detailed in another ITT article):
The International Trade Administration issued the preliminary results of its antidumping administrative review on polyvinyl alcohol from Taiwan (A-583-841).. The ITA calculated a preliminary zero AD rate for Chang Chun Petrochemical Co., Ltd., the sole respondent. If the ITA continues to find a zero AD rate for Chang Chun in the final results, it will instruct CBP to liquidate entries of the company's subject merchandise during the period of review without regard to AD duties. These preliminary results are not in effect. The ITA may modify them in the final results of this review and change the estimated AD cash deposit rate for this companies.
The International Trade Administration issued the final results of the antidumping duty administrative review on glycine from China (A-570-836). The ITA said Baoding Mantong, the only company under review, did not cooperate in the review, and so was assigned to the China-wide entity on the basis of adverse facts available (AFA). The ITA also rescinded the review for 25 companies that did not have shipments to the U.S. during the period of review. The new rates are effective April 8, and will be implemented by CBP soon.
The International Trade Administration issued the preliminary results of its countervailing duty administrative review on drill pipe from China (C-570-966) for Shanxi Yida Special Steel and its affiliates. These CV rates are not in effect. The ITA may modify them in the final results of this review and change the estimated CV cash deposit rates for these company.
The International Trade Commission is publishing notices in the April 3 Federal Register on the following AD/CV injury, Section 337 patent, and other trade proceedings (any notices that warrant a more detailed summary will appear in another ITT article):
The International Trade Administration published notices in the April 3 Federal Register on the following AD/CV duty proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms, or effective dates will be detailed in another ITT article):
The International Trade Commission is publishing notices in the April 2 Federal Register on the following AD/CV injury, Section 337 patent, and other trade proceedings (any notices that warrant a more detailed summary will appear in another ITT article):
The International Trade Commission is asking for comments by April 11 on public interest issues raised by ResMed’s Section 337 patent complaint on sleep-disordered breathing treatment systems and components (see 13040201). According to the underlying petition, the products are used in the treatment of obstructive sleep apnea by delivering pressurized air to the user to keep that user’s breathing passages open during sleep. ResMed alleges that Apex Medical and Drive Medical Design & Manufacturing manufacture and import breathing treatment systems that infringe its patents. ResMed is requesting cease and desist and limited exclusion orders against the respondents.
ResMed filed a Section 337 complaint with the International Trade Commission March 28, alleging imports of sleep-disordered breathing treatment systems and components from Apex Medical and Drive Medical Design & Manufacturing infringe its patents. The products are used in the treatment of obstructive sleep apnea by delivering pressurized air to the user to keep that user’s breathing passages open during sleep, the petition for investigation said. According to Resmed, Apex makes infringing breathing treatment systems abroad, and imports them into the U.S. through its affiliate Apex Medical USA. Medical Depot, which does business as Drive Medical Design & Manufacturing, also imports infringing breathing treatment systems it buys from Apex Medical, the complaint alleged. ResMed is requesting the ITC issue limited exclusion and cease and desist orders against the proposed respondents.
The International Trade Administration published notices in the April 2 Federal Register on the following AD/CV duty proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms, or effective dates will be detailed in another ITT article):